Neurocrine to conduct placebo-controlled study to investigate potential new treatment for schizophrenia
A phase 2 clinical trial for the treatment of schizophrenia has been accepted by the…
August 5, 2022 - 3 minutes
A phase 2 clinical trial for the treatment of schizophrenia has been accepted by the…
A bio-based vitamin B7 is the first product to be commercialized as biotech company, Biosyntia,…
Pfizer has agreed to invest €90.5 million ($95 million) towards a vaccination for Lyme disease. …